Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025

医薬品添加剤の世界市場予測(~2025年):有機化学品(炭水化物、石油化学)無機化学品

◆タイトル:Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025
◆商品コード:PH 3047
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年6月28日
◆ページ数:303
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、医薬品添加剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別(有機化学品(炭水化物、石油化学)無機化学品)分析、機能性別(増量剤、希釈剤、コーティング、崩壊剤)分析、製剤別(タブレット、カプセル、局所、非経口)分析、医薬品添加剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Increasing growth in the pharmaceutical drug market is expected to drive the growth of the pharmaceutical excipients market.”
The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%. The growth in this market can be attributed to factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals. However, certain barriers, such as the increasing regulatory stringency and the cost and time-intensive drug development process are expected to restrain the growth of this market to a certain extent during the forecast period.

“Organic chemicals segment to dominate the pharmaceutical excipients market in 2019.”

Based on product, the pharmaceutical excipients market is segmented into three major categories— organic chemicals, inorganic chemicals, and other chemicals. In 2018, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market. The large share of this segment can be attributed to the use of these chemicals in the majority of pharmaceutical formulations available in the pharmaceutical market. Also, the organic chemicals market had the highest CAGR above all.

“Advantages of topical drug delivery are driving demand for excipients in this segment.”

Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. Currently, there is a growing focus on the use of liposomes for the delivery of topical drugs. With this, there is a growing need for developing novel excipients that can improve the solubility and functionality of such formulations. Growth in this market segment is expected to play a major role in the growth of the pharmaceutical excipients market for topical formulations in the coming years.

“Europe accounted for the largest share of the market in 2018, whereas the Asia Pacific was the fastest growing market.”

The pharmaceutical excipients market is broadly divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe accounted for the largest share of the global pharmaceutical excipients market. The large share of this region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to high consumption of excipients. However, the Asia Pacific region is expected to be the fastest growing market. The factors driving the growth of this region can be attributed to the increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations -CMOs, rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor & manufacturing costs, and the large base for the generation of generics & biologics. The Asia Pacific market is expected to have the highest CAGR during the forecast period.

The breakup of primary participants is as mentioned below:
• By Company Type: Tier 1 – 48%, Tier 2 – 34%, and Tier 3 – 18%
• By Designation: C-level – 42%, Director-level – 36%, and Others – 22%
• By Region: Europe – 38%, North America – 34%, Asia Pacific – 17%, South America -7%, and the Middle East and Africa – 4%

The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. -US, BASF SE -Germany, DuPont de Nemours, Inc. -US, Roquette -France, Evonik Industries AG -Germany, Associated British Foods -UK, Archer Daniels Midland Company -US, Lubrizol Corporation -US, and Croda International -UK. Other players in this market are Innophos Holdings -US, Kerry Group -Ireland, WACKER Chemie AG -Germany, Colorcon -US, DFE Pharma -Germany, JRS Pharma -Germany, and Air Liquide S.A -France.
Research Coverage:
The report analyzes the pharmaceutical excipients market and aims at estimating the market size and future growth potential of this market based on various segments such as product, formulation, functionality, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the global pharmaceutical excipients market. The report analyzes this market by product, functionality, formulation, and region
• Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global pharmaceutical excipients market
• Market Development: Comprehensive information on the lucrative emerging markets by product, functionality, formulation, and region
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pharmaceutical excipients market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global pharmaceutical excipients market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 STAKEHOLDERS 28
1.6 LIMITATIONS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH APPROACH 30
2.1.1 SECONDARY RESEARCH 31
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY RESEARCH 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Breakdown of Primaries 32
2.1.2.3 Key industry insights 33
2.2 MARKET SIZE ESTIMATION 33
2.3 DATA TRIANGULATION APPROACH 35
2.4 MARKET SHARE ESTIMATION 35
2.5 ASSUMPTIONS FOR THE STUDY 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 41
4.1 PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW 41
4.2 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
4.3 REGIONAL MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2019–2025) 43
4.4 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION (2018) 44
4.5 PHARMACEUTICAL EXCIPIENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION) 45

5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
5.2.1 MARKET DRIVERS 47
5.2.1.1 Growth of the pharmaceuticals market backed by functional excipients 47
5.2.1.2 Surge in the generics market 48
5.2.1.3 Increasing uptake of biopharmaceuticals 49
5.2.1.4 Rising adoption of orphan drugs 50
5.2.2 MARKET RESTRAINTS 52
5.2.2.1 Cost and time-intensive drug development process 52
5.2.2.2 Increasing regulatory stringency 52
5.2.3 MARKET OPPORTUNITIES 54
5.2.3.1 Multifunctional excipients 54
5.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries 55
5.2.3.3 Growth in the biosimilars market 55
5.2.4 MARKET CHALLENGES 57
5.2.4.1 Safety and quality concerns 57
5.2.4.2 Changing trade policies between countries 58
6 INDUSTRY INSIGHTS 59
6.1 INTRODUCTION 59
6.2 INDUSTRY TRENDS 59
6.2.1 RISING DEMAND AND EMPHASIS ON CO-PROCESSED EXCIPIENTS 60
6.2.2 IMPROVING EXCIPIENT CAPABILITIES BY USING NANOTECHNOLOGY 61
6.2.3 INCREASING USE OF DIRECT COMPRESSION IN ORAL DOSAGE FORMULATIONS 62
6.2.4 PHARMACEUTICAL EXCIPIENTS INFLUENCING THE COST OF PRODUCTION 63
6.3 REGULATORY ANALYSIS 63
6.3.1 NORTH AMERICA 63
6.3.1.1 US 63
6.3.1.2 Canada 65
6.3.2 EUROPE 65
6.3.3 ASIA PACIFIC 66
6.3.3.1 Japan 66
6.3.3.2 China 67
6.3.3.3 India 68

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 69
7.1 INTRODUCTION 70
7.2 ORGANIC CHEMICALS 71
7.2.1 OLEOCHEMICALS 73
7.2.1.1 Fatty alcohols 75
7.2.1.1.1 Fatty alcohols are widely used as nonionic surfactants due to their amphipathic nature—a major driver for market growth 75
7.2.1.2 Mineral stearates 76
7.2.1.2.1 Market growth is due to the wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations 76
7.2.1.3 Glycerin 77
7.2.1.3.1 The extensive applications of glycerine are expected to drive growth in this market segment 77
7.2.1.4 Other oleochemicals 78
7.2.2 CARBOHYDRATES 79
7.2.2.1 Sugars 81
7.2.2.1.1 Actual sugars 82
7.2.2.1.1.1 Lactose 84
7.2.2.1.1.1.1 Being the most commonly used excipient in tablets and capsules, lactose captures a major share of the actual sugars market 84
7.2.2.1.1.2 Sucrose 84
7.2.2.1.1.2.1 Sucrose is extensively used in oral pharmaceutical formulations—a major factor driving market growth 84
7.2.2.1.1.3 Dextrose (D-Glucose) 84
7.2.2.1.1.3.1 Dextrose has a wide range of applications in tablets and capsules, which is a primary driver for adoption 84
7.2.2.1.2 Sugar alcohols 84
7.2.2.1.2.1 Mannitol 86
7.2.2.1.2.1.1 Mannitol is widely used with moisture-sensitive active ingredients as it is non-hygroscopic in nature; this is a major factor driving the adoption of this product 86
7.2.2.1.2.2 Sorbitol 86
7.2.2.1.2.2.1 Sorbitol is one of the most widely used compression diluents for pharmaceutical formulations owing to its various advantages 86
7.2.2.1.2.3 Other sugar alcohols 86
7.2.2.1.3 Artificial sweeteners 86
7.2.2.1.3.1 Gradual increase in utilization of artificial sweeteners due to regulatory acceptibility is expected to drive this market 86

7.2.2.2 Cellulose 87
7.2.2.2.1 Microcrystalline cellulose 89
7.2.2.2.1.1 Its highly compressible nature makes microcrystalline cellulose the most widely used excipient in the direct compression method for tablets 89
7.2.2.2.2 Cellulose ethers 90
7.2.2.2.2.1 Cellulose ethers are the most widely available polymers in nature, which is a major driving factor 90
7.2.2.2.3 CMC and croscarmellose sodium 91
7.2.2.2.3.1 The multiple advantages of CMC and croscarmellose sodium make them the most widely used binders, glidants, anti-adherents, and suspending agents in injectable preparations 91
7.2.2.2.4 Cellulose esters 92
7.2.2.2.4.1 Cellulose esters enable the delivery of drugs in cellular membranes and the intracellular matrix, which increases the demand for these substances 92
7.2.2.3 Starch 92
7.2.2.3.1 Modified starch 94
7.2.2.3.1.1 Modified starch is widely used in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities 94
7.2.2.3.2 Dried starch 95
7.2.2.3.2.1 Dried starch is a strong binding and coating agent, factors boosting adoption 95
7.2.2.3.3 Converted starch 96
7.2.2.3.3.1 Converted starch is used as a molecular encapsulation agent and offers enhanced solubility and stability for drugs 96
7.2.3 PETROCHEMICALS 97
7.2.3.1 Glycols 99
7.2.3.1.1 Polyethylene glycol 100
7.2.3.1.1.1 PEG is the excipient of choice in a large number of drug formulations due to its tunable properties and well-established safety profile 100
7.2.3.1.2 Propylene glycol 100
7.2.3.1.2.1 In high amounts, propylene glycol has been reported to be toxic among the pediatric population, which could be a restraining factor for market growth 100
7.2.3.2 Povidones 100
7.2.3.2.1 Rising demand for fast-dissolving tablets is expected to propel the market for povidones 100
7.2.3.3 Mineral hydrocarbons 101
7.2.3.3.1 Petrolatum 103
7.2.3.3.1.1 Increasing treatment rates for psoriasis, pruritus, eczema, and acne are driving the dermatology market, which in turn is expected to drive the growth of the petrolatum market 103

7.2.3.3.2 Mineral waxes 103
7.2.3.3.2.1 Being non-toxic and non-irritant by nature, they are most suitable for skin and eye preparations 103
7.2.3.3.3 Mineral oils 103
7.2.3.3.3.1 White mineral oils are good emollients, lubricating agents, and solvents, owing to which they are widely used in ointments 103
7.2.3.4 Acrylic polymers 103
7.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive the growth of this market 103
7.2.3.5 Other petrochemicals 104
7.2.4 PROTEINS 105
7.2.4.1 Rising application of proteins as carriers for microparticles and nanoparticles to drive this market 105
7.2.5 OTHER ORGANIC CHEMICALS 107
7.3 INORGANIC CHEMICALS 108
7.3.1 CALCIUM PHOSPHATE 110
7.3.1.1 Chemical purity and low incompatibility with drugs aid their high usage in the pharmaceutical industry 110
7.3.2 METAL OXIDES 111
7.3.2.1 Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth 111
7.3.3 HALITES 112
7.3.3.1 Increased utilization of halites in vaccines as well as controlled-release formulations is driving their demand in the market 112
7.3.4 CALCIUM CARBONATE 113
7.3.4.1 Properties such as short disintegration time and excellent mechanical strength for oral dosage formulations to drive the market 113
7.3.5 CALCIUM SULFATE 114
7.3.5.1 Calcium sulfate is a cost-effective, quality enhancing diluent for solid dosage forms 114
7.3.6 OTHER INORGANIC CHEMICALS 115
7.4 OTHER CHEMICALS 116
8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 117
8.1 INTRODUCTION 118
8.2 FILLERS & DILUENTS 119
8.2.1 DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE IN TABLETS 119
8.3 SUSPENDING & VISCOSITY AGENTS 121
8.3.1 SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY, MASKED TASTE OF INSOLUBLE INGREDIENTS, AND PROLONGED DRUG ACTION 121
8.4 COATING AGENTS 123
8.4.1 THE INCREASING UTILIZATION OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMACEUTICAL INDUSTRY IS DRIVING THIS MARKET SEGMENT 123

8.5 BINDERS 125
8.5.1 BINDERS PROVIDE THE PROPERTIES OF FLUIDITY AND COMPRESSIBILITY THAT ARE ESSENTIAL FOR TABLET MANUFACTURING 125
8.6 FLAVORING AGENTS & SWEETENERS 127
8.6.1 FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS 127
8.7 DISINTEGRANTS 128
8.7.1 DISINTEGRANTS ALLOW TABLETS AND CAPSULES TO PACK A POWERFUL PORTION OF MEDICATIONS IN A SMALL FORM THAT IS EASIER TO INGEST 128
8.8 COLORANTS 130
8.8.1 COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS 130
8.9 LUBRICANTS & GLIDANTS 131
8.9.1 GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTERPARTICLE FRICTION AND COHESION 131
8.10 PRESERVATIVES 133
8.10.1 BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY 133
8.11 EMULSIFYING AGENTS 134
8.11.1 THE USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE THE BIOAVAILABILITY OF THE API 134
8.12 OTHER FUNCTIONALITIES 136
9 PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION 138
9.1 INTRODUCTION 139
9.2 ORAL FORMULATIONS 140
9.2.1 TABLETS 142
9.2.1.1 Tablets are the most widely used dosage forms; this is a major contributing factor to market growth 142
9.2.2 CAPSULES 143
9.2.2.1 Hard gelatin capsules 145
9.2.2.1.1 The ease of manufacturing of hard gelatin capsules and the versatility of this dosage form are among the major factors driving the growth of the hard gelatin capsules market 145
9.2.2.2 Soft gelatin capsules 146
9.2.2.2.1 Stability concerns with highly water-soluble compounds and compounds susceptible to hydrolysis have been reported with the use of soft gels, which are restricting factors for market growth 146
9.2.3 LIQUID FORMULATIONS 147
9.2.3.1 No dissolution time and rapid absorption from stomach compare to tablet 147
9.3 TOPICAL FORMULATIONS 148
9.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY ARE DRIVING DEMAND FOR EXCIPIENTS IN THIS SEGMENT 148

9.4 PARENTERAL FORMULATIONS 150
9.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE THE DEMAND FOR EXCIPIENTS 150
9.5 OTHER FORMULATIONS 153
10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION 155
10.1 INTRODUCTION 156
10.2 EUROPE 157
10.2.1 GERMANY 163
10.2.1.1 Germany accounted for the largest share of the market in 2018 163
10.2.2 FRANCE 166
10.2.2.1 Stringent policies to support innovation pose regulatory challenges for the pharmaceutical excipients market in France 166
10.2.3 UK 169
10.2.3.1 Growing adoption of generics and the development of novel multi-functional co-processed excipients to drive market growth 169
10.2.4 SWITZERLAND 173
10.2.4.1 Large volume of pharmaceuticals produced in Switzerland provides huge potential for the utilization of pharmaceutical excipients 173
10.2.5 ITALY 176
10.2.5.1 Budgetary constraints and restricted healthcare spending to impede the growth of the Italian market 176
10.2.6 SPAIN 179
10.2.6.1 High consumption of biologics to support market growth 179
10.2.7 REST OF EUROPE 182
10.3 NORTH AMERICA 185
10.3.1 US 189
10.3.1.1 The US dominates the North American market due to the increasing use of biologics and the increasing per capita pharmaceutical spending 189
10.3.2 CANADA 193
10.3.2.1 Strong growth of the emerging markets and slowdown in new product approvals to hamper market growth in Canada 193
10.4 ASIA PACIFIC 196
10.4.1 JAPAN 201
10.4.1.1 Rapid growth of Japan’s geriatric population will greatly drive the demand for pharmaceuticals 201
10.4.2 CHINA 204
10.4.2.1 Chinese government has emphasized generics and off-patent drugs 204
10.4.3 INDIA 208
10.4.3.1 India is a leading producer of generics 208
10.4.4 SOUTH KOREA 211
10.4.4.1 Thriving generic drug market to support the growth of pharmaceutical excipients market in South Korea 211
10.4.5 REST OF ASIA PACIFIC 214
10.5 LATIN AMERICA 217
10.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE ARE DRIVING MARKET GROWTH 217
10.6 MIDDLE EAST AND AFRICA 220
10.6.1 UNSATURATED MARKETS IN THIS REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS 220
11 COMPETITIVE LANDSCAPE 224
11.1 INTRODUCTION 224
11.2 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET 225
11.3 COMPETITIVE LEADERSHIP MAPPING 226
11.3.1 VISIONARY LEADERS 226
11.3.2 INNOVATORS 226
11.3.3 DYNAMIC DIFFERENTIATORS 226
11.3.4 EMERGING COMPANIES 227
11.4 MARKET SHARE ANALYSIS 228
11.4.1 PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, 2018 228
11.5 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE 230
11.6 COMPETITIVE SITUATIONS AND TRENDS 231
12 COMPANY PROFILES 235
(Business overview, Products offered, Recent developments, MNM view, SWOT analysis)*
12.1 DUPONT DE NEMOURS, INC. 235
12.2 ROQUETTE FRÈRES 240
12.3 ASHLAND GLOBAL HOLDINGS INC. 245
12.4 EVONIK INDUSTRIES AG 250
12.5 BASF SE 254
12.6 KERRY GROUP PLC 260
12.7 CRODA INTERNATIONAL 263
12.8 ASSOCIATED BRITISH FOODS PLC 267
12.9 ARCHER DANIELS MIDLAND COMPANY 271
12.10 LUBRIZOL CORPORATION 274
12.11 INNOPHOS HOLDINGS INC. 277
12.12 WACKER CHEMIE AG 280
12.13 AIR LIQUIDE S.A. 283
12.14 COLORCON INC. 286
12.15 DMV-FONTERRA EXCIPIENTS GMBH & CO. KG 289
12.16 JRS PHARMA GMBH & CO. KG 290
*Business overview, Products offered, Recent developments, MNM view, SWOT analysis might not be captured in case of unlisted companies.

13 APPENDIX 292
13.1 INSIGHTS OF INDUSTRY EXPERTS 292
13.2 MARKET SIZING & VALIDATION APPROACH 293
13.3 DISCUSSION GUIDE 295
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 299
13.5 AVAILABLE CUSTOMIZATIONS 301
13.6 RELATED REPORTS 301
13.7 AUTHOR DETAILS 302

LIST OF TABLES

TABLE 1 DRUGS COMING OFF-PATENT 48
TABLE 2 KEY MARKET DRIVERS: IMPACT ANALYSIS 51
TABLE 3 KEY MARKET RESTRAINTS: IMPACT ANALYSIS 53
TABLE 4 MULTIFUNCTIONAL EXCIPIENTS 54
TABLE 5 CLINICAL STUDIES FOR BIOLOGICS & BIOSIMILARS (2017) 57
TABLE 6 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS 57
TABLE 7 KEY MARKET CHALLENGES: IMPACT ANALYSIS 58
TABLE 8 MARKETED CO-PROCESSED EXCIPIENTS 61
TABLE 9 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 70
TABLE 10 PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 71
TABLE 11 ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 72
TABLE 12 ORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 73
TABLE 13 OLEOCHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 74
TABLE 14 OLEOCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 74
TABLE 15 OLEOCHEMICALS: KEY BRANDS 74
TABLE 16 FATTY ALCOHOLS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 76
TABLE 17 MINERAL STEARATES MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 77
TABLE 18 GLYCERIN MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 78
TABLE 19 OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 79
TABLE 20 CARBOHYDRATES MARKET, BY TYPE, 2017–2025 (USD MILLION) 80
TABLE 21 CARBOHYDRATES MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 80
TABLE 22 CARBOHYDRATES: KEY BRANDS 81
TABLE 23 SUGARS MARKET, BY TYPE, 2017–2025 (USD MILLION) 81
TABLE 24 SUGARS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 82
TABLE 25 ACTUAL SUGARS MARKET, BY TYPE, 2017–2025 (USD MILLION) 83
TABLE 26 ACTUAL SUGARS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 83
TABLE 27 SUGAR ALCOHOLS MARKET, BY TYPE, 2017–2025 (USD MILLION) 85
TABLE 28 SUGAR ALCOHOLS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 85
TABLE 29 ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 87
TABLE 30 CELLULOSE MARKET, BY TYPE, 2017–2025 (USD MILLION) 88
TABLE 31 CELLULOSE MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 88
TABLE 32 MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 89
TABLE 33 CELLULOSE ETHERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 90
TABLE 34 CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 91
TABLE 35 CELLULOSE ESTERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 92
TABLE 36 STARCH MARKET, BY TYPE, 2017–2025 (USD MILLION) 93
TABLE 37 STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 93
TABLE 38 MODIFIED STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 94
TABLE 39 DRIED STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 95
TABLE 40 CONVERTED STARCH MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 96
TABLE 41 PETROCHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 97
TABLE 42 PETROCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 98
TABLE 43 PETROCHEMICALS: KEY BRANDS 98
TABLE 44 GLYCOLS MARKET, BY TYPE, 2017–2025 (USD MILLION) 99
TABLE 45 GLYCOLS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 99
TABLE 46 POVIDONES MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 101
TABLE 47 MINERAL HYDROCARBONS MARKET, BY TYPE, 2017–2025 (USD MILLION) 102
TABLE 48 MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 102
TABLE 49 ACRYLIC POLYMERS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 104
TABLE 50 OTHER PETROCHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 105
TABLE 51 PROTEINS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 106
TABLE 52 PROTEINS: KEY BRANDS 106
TABLE 53 OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 107
TABLE 54 OTHER ORGANIC CHEMICALS: KEY BRANDS 108
TABLE 55 INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 108
TABLE 56 INORGANIC CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 109
TABLE 57 INORGANIC CHEMICALS: KEY BRANDS 109
TABLE 58 CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 110
TABLE 59 METAL OXIDES MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 111
TABLE 60 HALITES MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 112
TABLE 61 CALCIUM CARBONATE MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 113
TABLE 62 CALCIUM SULFATE MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 114
TABLE 63 OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 115
TABLE 64 OTHER CHEMICALS MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 116
TABLE 65 OTHER CHEMICALS: KEY BRANDS 116
TABLE 66 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 119
TABLE 67 PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 120
TABLE 68 EXCIPIENTS FOR FILLERS AND DILUENTS 121
TABLE 69 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION) 122
TABLE 70 EXCIPIENTS FOR SUSPENDING AND VISCOSITY AGENTS 122
TABLE 71 PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 124
TABLE 72 EXCIPIENTS FOR COATING AGENTS 124
TABLE 73 PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY/REGION, 2017–2025 (USD MILLION) 126
TABLE 74 EXCIPIENTS FOR BINDERS 126
TABLE 75 PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY/REGION, 2017–2025 (USD MILLION) 127
TABLE 76 EXCIPIENTS FOR FLAVORING AGENTS 128
TABLE 77 PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 129
TABLE 78 EXCIPIENTS FOR DISINTEGRANTS 129
TABLE 79 PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 130
TABLE 80 EXCIPIENTS FOR COLORANTS 131
TABLE 81 PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 132
TABLE 82 EXCIPIENTS FOR LUBRICANTS AND GLIDANTS 132
TABLE 83 PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 133
TABLE 84 EXCIPIENTS FOR PRESERVATIVES 134
TABLE 85 PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS,
BY COUNTRY/REGION, 2017–2025 (USD MILLION) 135
TABLE 86 EXCIPIENTS FOR EMULSIFYING AGENTS 135
TABLE 87 OTHER FUNCTIONALITIES MARKET, BY COUNTRY/REGION,
2017–2025 (USD MILLION) 137
TABLE 88 EXCIPIENTS FOR OTHER FUNCTIONALITIES 137
TABLE 89 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 139
TABLE 90 EXCIPIENTS FOR ORAL FORMULATIONS 140
TABLE 91 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2017–2025 (USD MILLION) 141
TABLE 92 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2017–2025 (USD MILLION) 141
TABLE 93 TYPICAL COMPOSITION OF TABLETS 142
TABLE 94 PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY,
2017–2025 (USD MILLION) 143
TABLE 95 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,
2017–2025 (USD MILLION) 144
TABLE 96 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY,
2017–2025 (USD MILLION) 144
TABLE 97 PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD GELATIN CAPSULES,
BY COUNTRY, 2017–2025 (USD MILLION) 145
TABLE 98 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT GELATIN CAPSULES,
BY COUNTRY, 2017–2025 (USD MILLION) 146
TABLE 99 PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS,
BY COUNTRY, 2017–2025 (USD MILLION) 148
TABLE 100 EXCIPIENTS FOR TOPICAL FORMULATIONS 149
TABLE 101 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS,
BY COUNTRY, 2017–2025 (USD MILLION) 150
TABLE 102 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS 151
TABLE 103 EXCIPIENTS USED IN PARENTERAL FORMULATIONS 151
TABLE 104 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS,
BY COUNTRY, 2017–2025 (USD MILLION) 152
TABLE 105 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS,
BY COUNTRY, 2017–2025 (USD MILLION) 154
TABLE 106 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2017–2025 (USD MILLION) 157
TABLE 107 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 160
TABLE 108 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 160
TABLE 109 EUROPE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 161
TABLE 110 EUROPE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 161
TABLE 111 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 162
TABLE 112 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION,
2017–2025 (USD MILLION) 162
TABLE 113 GERMANY: KEY MICROINDICATORS 163
TABLE 114 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 164
TABLE 115 GERMANY: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 164
TABLE 116 GERMANY: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 164
TABLE 117 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 165
TABLE 118 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION,
2017–2025 (USD MILLION) 165
TABLE 119 FRANCE: KEY MICROINDICATORS 167
TABLE 120 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 167
TABLE 121 FRANCE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 167
TABLE 122 FRANCE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 168
TABLE 123 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 168
TABLE 124 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION,
2017–2025 (USD MILLION) 169
TABLE 125 UK: KEY MICROINDICATORS 170
TABLE 126 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 170
TABLE 127 UK: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 171
TABLE 128 UK: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 171
TABLE 129 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 172
TABLE 130 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 172
TABLE 131 SWITZERLAND: KEY MICROINDICATORS 173
TABLE 132 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 174
TABLE 133 SWITZERLAND: ORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 174
TABLE 134 SWITZERLAND: INORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 175
TABLE 135 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION) 175
TABLE 136 SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION,
2017–2025 (USD MILLION) 176
TABLE 137 ITALY: KEY MICROINDICATORS 177
TABLE 138 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 177
TABLE 139 ITALY: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 177
TABLE 140 ITALY: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 178
TABLE 141 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 178
TABLE 142 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, FORMULATION,
2017–2025 (USD MILLION) 179
TABLE 143 SPAIN: KEY MICROINDICATORS 180
TABLE 144 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 180
TABLE 145 SPAIN: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 180
TABLE 146 SPAIN: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 181
TABLE 147 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 181
TABLE 148 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 182
TABLE 149 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 183
TABLE 150 ROE: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 183
TABLE 151 ROE: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 184
TABLE 152 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 184
TABLE 153 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 185
TABLE 154 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 187
TABLE 155 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 187
TABLE 156 NORTH AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 187
TABLE 157 NORTH AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 188
TABLE 158 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION) 188
TABLE 159 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION) 189
TABLE 160 US: KEY MICROINDICATORS 190
TABLE 161 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 190
TABLE 162 US: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 191
TABLE 163 US: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 191
TABLE 164 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 192
TABLE 165 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 192
TABLE 166 CANADA: KEY MICROINDICATORS 193
TABLE 167 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 194
TABLE 168 CANADA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 194
TABLE 169 CANADA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 195
TABLE 170 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 195
TABLE 171 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 196
TABLE 172 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 198
TABLE 173 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 198
TABLE 174 ASIA PACIFIC: ORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 199
TABLE 175 ASIA PACIFIC: INORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 199
TABLE 176 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 200
TABLE 177 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 200
TABLE 178 JAPAN: KEY MICROINDICATORS 201
TABLE 179 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 202
TABLE 180 JAPAN: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 202
TABLE 181 JAPAN: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 203
TABLE 182 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 203
TABLE 183 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 204
TABLE 184 CHINA: KEY MICROINDICATORS 205
TABLE 185 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 205
TABLE 186 CHINA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 206
TABLE 187 CHINA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 206
TABLE 188 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 207
TABLE 189 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 207
TABLE 190 INDIA: KEY MICROINDICATORS 209
TABLE 191 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 209
TABLE 192 INDIA: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 209
TABLE 193 INDIA: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 210
TABLE 194 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 210
TABLE 195 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 211
TABLE 196 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 212
TABLE 197 SOUTH KOREA: ORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 212
TABLE 198 SOUTH KOREA: INORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 213
TABLE 199 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION) 213
TABLE 200 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 214
TABLE 201 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 215
TABLE 202 ROAPAC: ORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 215
TABLE 203 ROAPAC: INORGANIC CHEMICALS MARKET, BY TYPE, 2017–2025 (USD MILLION) 216
TABLE 204 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2017–2025 (USD MILLION) 216
TABLE 205 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2017–2025 (USD MILLION) 217
TABLE 206 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2017–2025 (USD MILLION) 218
TABLE 207 LATIN AMERICA: ORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 218
TABLE 208 LATIN AMERICA: INORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 219
TABLE 209 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017–2025 (USD MILLION) 219
TABLE 210 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2017–2025 (USD MILLION) 220
TABLE 211 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2017–2025 (USD MILLION) 221
TABLE 212 MIDDLE EAST AND AFRICA: ORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 221
TABLE 213 MIDDLE EAST AND AFRICA: INORGANIC CHEMICALS MARKET, BY TYPE,
2017–2025 (USD MILLION) 222
TABLE 214 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FUNCTIONALITY, 2017–2025 (USD MILLION) 222
TABLE 215 MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FORMULATION, 2017–2025 (USD MILLION) 223
TABLE 216 PRODUCT LAUNCHES (2018-2019) 231
TABLE 217 MERGERS AND ACQUISITIONS (2017-2019) 231
TABLE 218 AGREEMENTS AND PARTNERSHIPS (2018-2019) 232
TABLE 219 EXPANSIONS (2018-2019) 233
TABLE 220 OTHER DEVELOPMENTS (2016-2018) 234


LIST OF FIGURES

FIGURE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET 27
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS,
AND REGION 32
FIGURE 4 BOTTOM-UP APPROACH 34
FIGURE 5 TOP-DOWN APPROACH 34
FIGURE 6 DATA TRIANGULATION METHODOLOGY 35
FIGURE 7 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2019 VS. 2025 (USD MILLION) 37
FIGURE 8 ORGANIC CHEMICALS MARKET, BY TYPE, 2019 VS. 2025 (USD MILLION) 38
FIGURE 9 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2019 VS. 2025 (USD MILLION) 38
FIGURE 10 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2019 VS. 2025 (USD MILLION) 39
FIGURE 11 GEOGRAPHICAL SNAPSHOT: PHARMACEUTICAL EXCIPIENTS MARKET 40
FIGURE 12 GROWING PHARMACEUTICALS INDUSTRY COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS ARE KEY FACTORS DRIVING MARKET GROWTH 41
FIGURE 13 ASIA PACIFIC IS PROJECTED TO SHOW THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 42
FIGURE 14 EUROPE TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD (2018–2023) 43
FIGURE 15 ORAL FORMULATION ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2018 44
FIGURE 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 45
FIGURE 17 PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 46
FIGURE 18 GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022) 47
FIGURE 19 GROWTH OF THE GENERICS MARKET, 2006 VS 2016 49
FIGURE 20 INCREASING PENETRATION OF ORPHAN DRUGS (2010–2024) 50
FIGURE 21 RISING NUMBER OF ORPHAN INDICATIONS APPROVED IN THE US 51
FIGURE 22 ESTIMATED PRE-APPROVAL COST OF BRINGING A NEW CHEMICAL OR BIOLOGICAL ENTITY TO MARKET (1970–2010) 52
FIGURE 23 TOTAL NUMBER OF NEW MOLECULAR ENTITY (NME) & NEW BIOLOGIC LICENSE APPLICATION (BLA) FILINGS AND APPROVALS IN THE US, 2006–2018 56
FIGURE 24 INCREASING FOCUS ON CO-PROCESSED EXCIPIENTS AND USE OF NANOTECHNOLOGY IN EXCIPIENT PRODUCTION ARE THE LEADING TRENDS IN
THE INDUSTRY 59
FIGURE 25 ORGANIC CHEMICALS SEGMENT TO DOMINATE THE PHARMACEUTICAL EXCIPIENTS MARKET IN 2019 70
FIGURE 26 OLEOCHEMICALS ARE EXPECTED TO DOMINATE THE ORGANIC CHEMICALS MARKET DURING THE FORECAST PERIOD 72
FIGURE 27 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2019 VS. 2025 118
FIGURE 28 ORAL FORMULATIONS TO FORM THE LARGEST SEGMENT IN THE PHARMACEUTICAL EXCIPIENTS MARKET DURING THE FORECAST PERIOD 139
FIGURE 29 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC SNAPSHOT 156
FIGURE 30 EUROPE PHARMACEUTICAL PRODUCTION, 2015 VS. 2016 (USD BILLION) 158
FIGURE 31 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 159
FIGURE 32 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 186
FIGURE 33 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 197
FIGURE 34 KEY DEVELOPMENTS IN THE PHARMACEUTICAL EXCIPIENTS MARKET BETWEEN 2016 AND 2019 224
FIGURE 35 GEOGRAPHICAL REVENUE MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2018) 225
FIGURE 36 PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018) 227
FIGURE 37 PHARMACEUTICAL EXCIPIENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2018) 228
FIGURE 38 R&D EXPENDITURE: MAJOR PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET 2017 & 2018 230
FIGURE 39 DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT (2018) 235
FIGURE 40 ROQUETTE FRÈRES: COMPANY SNAPSHOT (2017) 240
FIGURE 41 ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT (2018) 245
FIGURE 42 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2018) 250
FIGURE 43 BASF SE: COMPANY SNAPSHOT (2018) 254
FIGURE 44 KERRY GROUP PLC: COMPANY SNAPSHOT (2018) 260
FIGURE 45 CRODA INTERNATIONAL: COMPANY SNAPSHOT (2018) 263
FIGURE 46 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2018) 267
FIGURE 47 ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT (2018) 271
FIGURE 48 INNOPHOS HOLDINGS INC: COMPANY SNAPSHOT (2018) 277
FIGURE 49 WACKER CHEMIE AG: COMPANY SNAPSHOT (2018) 280
FIGURE 50 AIR LIQUIDE S.A.: COMPANY SNAPSHOT (2018) 283


★調査レポート[医薬品添加剤の世界市場予測(~2025年):有機化学品(炭水化物、石油化学)無機化学品] ( Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025 / PH 3047) 販売に関する免責事項
[医薬品添加剤の世界市場予測(~2025年):有機化学品(炭水化物、石油化学)無機化学品] ( Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025 / PH 3047) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆